Conference Detail Page

Update on Attention Deficit Hyperactivity Disorder Through the Lifespan

CME : 7.25
Start Date :  Dec 05 - 2020 End Date :  Dec 05 - 2020

Organized by :   NYU Grossman School of Medicine

Specialities :   Psychiatry, Pediatrics, Behavioral Health, Child and Adolescent Psychiatry

Conference Summary

Update on Attention Deficit Hyperactivity Disorder Through the Lifespan is organized by NYU Grossman School of Medicine. This Online CME Course will be held on Dec 05, 2020.

How many CME/CE credits can be earned by attending Update on Attention Deficit Hyperactivity Disorder Through the Lifespan Online CME Course?

Accreditation:
Credit Designation Statement:

The NYU Grossman School of Medicine assigns this online CME activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians will be able to earn only the credit commensurate with the extent of their participation in the activity.

What is the significance of Update on Attention Deficit Hyperactivity Disorder Through the Lifespan Online CME Course?

Course Description:
ThisCME webcast will concentrate on the current issues in attention deficit hyperactivity disorder (ADHD) through the lifespan (in children, adolescents, and adults). The CM course will be a full-day activity with a virtual breakout "Ask the Experts" session where attendees will be capable to ask clinical questions of three of the expert course panelists. Topics to be incorporated include treatment of adult ADHD, ADHD and substance usage of disorders, neuroimaging of ADHD, mind wandering, meta-analyses of ADHD medications for children, adolescents, and adults, diagnosing adult ADHD, sluggish cognitive tempo, and psychosocial updates.

What are the benefits of Update on Attention Deficit Hyperactivity Disorder Through the Lifespan Online CME Course?

Course Objectives:
At the conclusion of this Online CME activity, clinicians should be able to:
• Review their screening protocols for ADHD focusing on improving the screening of female child and adolescent patients
• Screen their adult patients who have been diagnosed with depression, anxiety, or substance use disorder for ADHD
• Assess their prevailing practice regarding the pharmacological treatment of children and adults with ADHD
• Explain the high rates of overlap of substance use disorders and ADHD.

Credit Info

  • CME : 7.25
Speaker (s)
7 Speakers
Target Audience

Physicians.

Peers Info
Number of Health Care Professionals Registered: 2 Number
Contact Us

Toll free Number

1(800) 826-2059

Email

support@eMedEvents.com

Chat Assistant

Live Chat